Product pipeline      Malaria      Hepatitis C      Ebola and Marburg      Influenza      Respiratory Syncytial Virus      

Send by emailPrint this page

Our research and development programme focuses on genetic vaccines to target diseases for which there is currently no effective prophylactic or therapeutic vaccine.